(Bloomberg) -- An injection that's more popular than a pill? That's the case for Novo Nordisk A/S's Saxenda shot for obesity. While the injection may be less pleasant than taking a pill, it's effective: Saxenda and Vivus Inc.'s Qsymia have the highest odds of achieving at least a 5 percent reduction in weight, according to data published in June.
--With assistance from Doni Bloomfield To contact the reporter on this story: Kristen Hallam in London at khallam@bloomberg.net. To contact the editors responsible for this story: Chitra Somayaji at csomayaji@bloomberg.net, Marthe Fourcade
Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.
